The pricing determination for HCPCS code E3200 will take effect on April 1, 2025 PORTLAND, Maine, Jan. 16, 2025 /PRNewswire/ — MedRhythms, Inc. today announced that InTandem®, the company’s flagship rehabilitation system for chronic stroke gait impairment, received a final pricing…
Tag: Medrhythms
MedRhythms Announces FDA Listing of InTandem™ (MR-001) to Improve Walking and Ambulation in Adults with Chronic Stroke
Stroke is a leading cause of long-term disability, and over half of people aged 65 or older who have had a stroke experience reduced mobility and gait deficits PORTLAND, Maine, July 6, 2023 /PRNewswire/ — MedRhythms today announced that MR-001, the company’s evidence-based neurorehabilitation system to improve walking and ambulation in adults with chronic […]